[Tamoxifen treatment and pulmunary embolism: a case report and literature review].
Breast carcinoma is becoming a spread disease that needs a specif teraphy. Tamoxifen is the first line treatment in patients with positivity of expression of estrogen receptors. The risk of thromboembolism is high in patients treated with tamoxifene indipendent from the neoplastic disease. This work focuses the attention on tamoxifen mechanism of thrombosis.
U.O. C. Cardiologia/UTIC, Ospedale La Memoria di Gavardo, Via Gosa 74, I-25085 Gavardo (Brescia), Italy. gregoriana.zanini@aod.it
Gregoriana
G
Zanini
Benedetta
B
Fontanella
Marco
M
Racheli
Monica
M
Bortolotti
Gian Franco
GF
Pasini
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D006801:Humans; D011655:Pulmonary Embolism / Q000139:chemically induced* / Q000175:diagnosis; D013629:Tamoxifen / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen